معرفی
Dr Rachel Dickinson is a researcher affiliated with Newcastle University, specializing in immunology, genetics, and hematological disorders. Her work focuses on primary immunodeficiencies, particularly those linked to GATA2 mutations, and the role of dendritic cells, monocytes, and NK cells in immune dysregulation.
Her research has explored the pathogenesis of DCML deficiency (Dendritic Cell, Monocyte, B, and NK Lymphoid deficiency), the application of reduced-intensity stem cell transplantation for treating GATA2-related disorders, and the epigenetic regulation of tumor suppressor genes like SLIT/ROBO pathways.
Key trends in her publications include the genetic basis of immune dysfunction, the cellular mechanisms of dendritic cell and monocyte depletion, and the use of exome sequencing for diagnosing primary immunodeficiencies. Collaborative studies highlight the importance of GATA2 signaling in hematopoiesis and the therapeutic potential of stem cell interventions.
